18F-fluoromisonidazole quantification of hypoxia in human cancer patients using image-derived blood surrogate tissue reference regions

Mark Muzi, Lanell M. Peterson, Janet N. O'Sullivan, James R. Fink, Joseph G. Rajendran, Lena J. McLaughlin, John P. Muzi, David A. Mankoff, Kenneth Krohn

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

18F-fluoromisonidazole (18F-FMISO) is the most widely used PET agent for imaging hypoxia, a condition associated with resistance to tumor therapy. 18F-FMISO equilibrates in normoxic tissues but is retained under hypoxic conditions because of reduction and binding to macromolecules. A simple tissue-to-blood (TB) ratio is suitable for quantifying hypoxia. A TB ratio threshold of 1.2 or greater is useful in discriminating the hypoxic volume (HV) of tissue; TBmax is the maximum intensity of the hypoxic region and does not invoke a threshold. Because elimination of blood sampling would simplify clinical use, we tested the validity of using imaging regions as a surrogate for blood sampling. Methods: Patients underwent 20-min 18F-FMISO scanning during the 90-to 140-min interval after injection with venous blood sampling. Two hundred twenty-three 18FFMISO patient studies had detectable surrogate blood regions in the field of view. Quantitative parameters of hypoxia (TBmax, HV) derived from blood samples were compared with values using surrogate blood regions derived from the heart, aorta, or cerebellum. In a subset of brain cancer patients, parameters from blood samples and from the cerebellum were compared for their ability to independently predict outcome. Results: Vascular regions of heart showed the highest correlation to measured blood activity (R2 5 0.84). For brain studies, cerebellar activity was similarly correlated to blood samples. In brain cancer patients, Kaplan-Meier analysis showed that image-derived reference regions had predictive power nearly identical to parameters derived from blood, thus obviating the need for venous sampling in these patients. Conclusion: Simple static analysis of 18F-FMISO PET captures both the intensity (TBmax) and the spatial extent (HV) of tumor hypoxia. An image-derived region to assess blood activity can be used as a surrogate for blood sampling in quantification of hypoxia.

Original languageEnglish (US)
Pages (from-to)1223-1228
Number of pages6
JournalJournal of Nuclear Medicine
Volume56
Issue number8
DOIs
StatePublished - Aug 1 2015
Externally publishedYes

Fingerprint

Neoplasms
Brain Neoplasms
fluoromisonidazole
Hypoxia
Cerebellum
Kaplan-Meier Estimate
Blood Volume
Blood Vessels
Aorta
Injections
Brain

Keywords

  • <sup>18</sup>F-FMISO
  • Hypoxia
  • PET
  • Quantitation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

18F-fluoromisonidazole quantification of hypoxia in human cancer patients using image-derived blood surrogate tissue reference regions. / Muzi, Mark; Peterson, Lanell M.; O'Sullivan, Janet N.; Fink, James R.; Rajendran, Joseph G.; McLaughlin, Lena J.; Muzi, John P.; Mankoff, David A.; Krohn, Kenneth.

In: Journal of Nuclear Medicine, Vol. 56, No. 8, 01.08.2015, p. 1223-1228.

Research output: Contribution to journalArticle

Muzi, M, Peterson, LM, O'Sullivan, JN, Fink, JR, Rajendran, JG, McLaughlin, LJ, Muzi, JP, Mankoff, DA & Krohn, K 2015, '18F-fluoromisonidazole quantification of hypoxia in human cancer patients using image-derived blood surrogate tissue reference regions', Journal of Nuclear Medicine, vol. 56, no. 8, pp. 1223-1228. https://doi.org/10.2967/jnumed.115.158717
Muzi, Mark ; Peterson, Lanell M. ; O'Sullivan, Janet N. ; Fink, James R. ; Rajendran, Joseph G. ; McLaughlin, Lena J. ; Muzi, John P. ; Mankoff, David A. ; Krohn, Kenneth. / 18F-fluoromisonidazole quantification of hypoxia in human cancer patients using image-derived blood surrogate tissue reference regions. In: Journal of Nuclear Medicine. 2015 ; Vol. 56, No. 8. pp. 1223-1228.
@article{f0d863d67feb4d9c8a8a66cbc5530822,
title = "18F-fluoromisonidazole quantification of hypoxia in human cancer patients using image-derived blood surrogate tissue reference regions",
abstract = "18F-fluoromisonidazole (18F-FMISO) is the most widely used PET agent for imaging hypoxia, a condition associated with resistance to tumor therapy. 18F-FMISO equilibrates in normoxic tissues but is retained under hypoxic conditions because of reduction and binding to macromolecules. A simple tissue-to-blood (TB) ratio is suitable for quantifying hypoxia. A TB ratio threshold of 1.2 or greater is useful in discriminating the hypoxic volume (HV) of tissue; TBmax is the maximum intensity of the hypoxic region and does not invoke a threshold. Because elimination of blood sampling would simplify clinical use, we tested the validity of using imaging regions as a surrogate for blood sampling. Methods: Patients underwent 20-min 18F-FMISO scanning during the 90-to 140-min interval after injection with venous blood sampling. Two hundred twenty-three 18FFMISO patient studies had detectable surrogate blood regions in the field of view. Quantitative parameters of hypoxia (TBmax, HV) derived from blood samples were compared with values using surrogate blood regions derived from the heart, aorta, or cerebellum. In a subset of brain cancer patients, parameters from blood samples and from the cerebellum were compared for their ability to independently predict outcome. Results: Vascular regions of heart showed the highest correlation to measured blood activity (R2 5 0.84). For brain studies, cerebellar activity was similarly correlated to blood samples. In brain cancer patients, Kaplan-Meier analysis showed that image-derived reference regions had predictive power nearly identical to parameters derived from blood, thus obviating the need for venous sampling in these patients. Conclusion: Simple static analysis of 18F-FMISO PET captures both the intensity (TBmax) and the spatial extent (HV) of tumor hypoxia. An image-derived region to assess blood activity can be used as a surrogate for blood sampling in quantification of hypoxia.",
keywords = "<sup>18</sup>F-FMISO, Hypoxia, PET, Quantitation",
author = "Mark Muzi and Peterson, {Lanell M.} and O'Sullivan, {Janet N.} and Fink, {James R.} and Rajendran, {Joseph G.} and McLaughlin, {Lena J.} and Muzi, {John P.} and Mankoff, {David A.} and Kenneth Krohn",
year = "2015",
month = "8",
day = "1",
doi = "10.2967/jnumed.115.158717",
language = "English (US)",
volume = "56",
pages = "1223--1228",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "8",

}

TY - JOUR

T1 - 18F-fluoromisonidazole quantification of hypoxia in human cancer patients using image-derived blood surrogate tissue reference regions

AU - Muzi, Mark

AU - Peterson, Lanell M.

AU - O'Sullivan, Janet N.

AU - Fink, James R.

AU - Rajendran, Joseph G.

AU - McLaughlin, Lena J.

AU - Muzi, John P.

AU - Mankoff, David A.

AU - Krohn, Kenneth

PY - 2015/8/1

Y1 - 2015/8/1

N2 - 18F-fluoromisonidazole (18F-FMISO) is the most widely used PET agent for imaging hypoxia, a condition associated with resistance to tumor therapy. 18F-FMISO equilibrates in normoxic tissues but is retained under hypoxic conditions because of reduction and binding to macromolecules. A simple tissue-to-blood (TB) ratio is suitable for quantifying hypoxia. A TB ratio threshold of 1.2 or greater is useful in discriminating the hypoxic volume (HV) of tissue; TBmax is the maximum intensity of the hypoxic region and does not invoke a threshold. Because elimination of blood sampling would simplify clinical use, we tested the validity of using imaging regions as a surrogate for blood sampling. Methods: Patients underwent 20-min 18F-FMISO scanning during the 90-to 140-min interval after injection with venous blood sampling. Two hundred twenty-three 18FFMISO patient studies had detectable surrogate blood regions in the field of view. Quantitative parameters of hypoxia (TBmax, HV) derived from blood samples were compared with values using surrogate blood regions derived from the heart, aorta, or cerebellum. In a subset of brain cancer patients, parameters from blood samples and from the cerebellum were compared for their ability to independently predict outcome. Results: Vascular regions of heart showed the highest correlation to measured blood activity (R2 5 0.84). For brain studies, cerebellar activity was similarly correlated to blood samples. In brain cancer patients, Kaplan-Meier analysis showed that image-derived reference regions had predictive power nearly identical to parameters derived from blood, thus obviating the need for venous sampling in these patients. Conclusion: Simple static analysis of 18F-FMISO PET captures both the intensity (TBmax) and the spatial extent (HV) of tumor hypoxia. An image-derived region to assess blood activity can be used as a surrogate for blood sampling in quantification of hypoxia.

AB - 18F-fluoromisonidazole (18F-FMISO) is the most widely used PET agent for imaging hypoxia, a condition associated with resistance to tumor therapy. 18F-FMISO equilibrates in normoxic tissues but is retained under hypoxic conditions because of reduction and binding to macromolecules. A simple tissue-to-blood (TB) ratio is suitable for quantifying hypoxia. A TB ratio threshold of 1.2 or greater is useful in discriminating the hypoxic volume (HV) of tissue; TBmax is the maximum intensity of the hypoxic region and does not invoke a threshold. Because elimination of blood sampling would simplify clinical use, we tested the validity of using imaging regions as a surrogate for blood sampling. Methods: Patients underwent 20-min 18F-FMISO scanning during the 90-to 140-min interval after injection with venous blood sampling. Two hundred twenty-three 18FFMISO patient studies had detectable surrogate blood regions in the field of view. Quantitative parameters of hypoxia (TBmax, HV) derived from blood samples were compared with values using surrogate blood regions derived from the heart, aorta, or cerebellum. In a subset of brain cancer patients, parameters from blood samples and from the cerebellum were compared for their ability to independently predict outcome. Results: Vascular regions of heart showed the highest correlation to measured blood activity (R2 5 0.84). For brain studies, cerebellar activity was similarly correlated to blood samples. In brain cancer patients, Kaplan-Meier analysis showed that image-derived reference regions had predictive power nearly identical to parameters derived from blood, thus obviating the need for venous sampling in these patients. Conclusion: Simple static analysis of 18F-FMISO PET captures both the intensity (TBmax) and the spatial extent (HV) of tumor hypoxia. An image-derived region to assess blood activity can be used as a surrogate for blood sampling in quantification of hypoxia.

KW - <sup>18</sup>F-FMISO

KW - Hypoxia

KW - PET

KW - Quantitation

UR - http://www.scopus.com/inward/record.url?scp=84938872102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938872102&partnerID=8YFLogxK

U2 - 10.2967/jnumed.115.158717

DO - 10.2967/jnumed.115.158717

M3 - Article

C2 - 26112020

AN - SCOPUS:84938872102

VL - 56

SP - 1223

EP - 1228

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 8

ER -